Dutch Researchers Rank Higher than the Top 10 Most Research-Intensive Nations In Key Research Performance Areas
Elsevier analysis reveals that international collaboration and mobility push Dutch research performance to global topAmsterdam, May 6, 2013
Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced the outcomes of a comparative study of Dutch researchers’ international performance. The study, based on Scopus data and using Elsevier’s SciVal research performance measurement tools, showed that in a comparison that includes the top 10 R&D spending nations in the world, the Netherlands ranks No. 1 in publication impact per article and number 1 by level of international collaboration.
Furthermore, within this group the Netherlands ranks number 1 in the world in citations generated per unit of R&D spending and number 2 in publications generated per unit of R&D spending. The figures were presented at the Impact of Science Conference held in Amsterdam.
Nick Fowler, Elsevier’s Managing Director of A&G Institutional Markets, said: “Two factors contribute to the success of the Netherlands: international collaboration and a geographically mobile research base. 48.7% of articles written by a Netherlands-based researcher are written in collaboration with a researcher outside the Netherlands. This is a higher proportion than any of the top 10 R&D-spending nations in the world. International collaboration is generally acknowledged as a positive force driving research impact and prestige. The second factor, the mobile research base, relates to what we call ‘brain circulation’, or cross-border mobility of researchers. The Netherlands has a history of allowing people to move in and out, also in the science world. For example no less than 74% of authors affiliated with Dutch institutions have also published at an institution in another country at some point in their careers. That hugely benefits Dutch research.”
# # #
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
+31 20 485 2736